Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Ebiomedicine
|
July 1, 2025
Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19
Mary Lynn Baniecki, Shunjie Guan, Devendra K Rai, et al.
The New England Journal of Medicine
|
February 16, 2022
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
September 9, 2025
Standardizing early cerebral palsy detection in high-risk infants: reducing age at diagnosis through a quality improvement initiative
Sylvan Ryder, Mallory Kerner-Rossi, Sandhya Brachio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2024
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial
Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
The Pediatric Infectious Disease Journal
|
February 25, 2020
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis
John S Bradley, Gregory G Stone, Phylinda L S Chan, et al.
The New England Journal of Medicine
|
July 17, 2024
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
Jennifer Hammond, Carla Yunis, Robert J Fountaine, et al.
The New England Journal of Medicine
|
April 10, 2024
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Jennifer Hammond, Robert J Fountaine, Carla Yunis, et al.
Prenatal Diagnosis
|
March 16, 2021
Dealing with uncertain results from chromosomal microarray and exome sequencing in the prenatal setting: An international cross-sectional study with healthcare professionals
Celine Lewis, Jennifer Hammond, Jasmijn E Klapwijk, et al.
Plos One
|
January 28, 2022
Assessing women's preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design
Jennifer Hammond, Jasmijn E Klapwijk, Sam Riedijk, et al.
Pediatrics
|
June 24, 2026
Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older
Jacqueline Gerhart, Heidi Leister-Tebbe, Phylinda L S Chan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Ebiomedicine
|
July 1, 2025
Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19
Mary Lynn Baniecki, Shunjie Guan, Devendra K Rai, et al.
The New England Journal of Medicine
|
February 16, 2022
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
September 9, 2025
Standardizing early cerebral palsy detection in high-risk infants: reducing age at diagnosis through a quality improvement initiative
Sylvan Ryder, Mallory Kerner-Rossi, Sandhya Brachio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2024
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A Phase 3 Randomized Trial
Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, et al.
The Pediatric Infectious Disease Journal
|
February 25, 2020
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis
John S Bradley, Gregory G Stone, Phylinda L S Chan, et al.
The New England Journal of Medicine
|
July 17, 2024
Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
Jennifer Hammond, Carla Yunis, Robert J Fountaine, et al.
The New England Journal of Medicine
|
April 10, 2024
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Jennifer Hammond, Robert J Fountaine, Carla Yunis, et al.
Prenatal Diagnosis
|
March 16, 2021
Dealing with uncertain results from chromosomal microarray and exome sequencing in the prenatal setting: An international cross-sectional study with healthcare professionals
Celine Lewis, Jennifer Hammond, Jasmijn E Klapwijk, et al.
Plos One
|
January 28, 2022
Assessing women's preferences towards tests that may reveal uncertain results from prenatal genomic testing: Development of attributes for a discrete choice experiment, using a mixed-methods design
Jennifer Hammond, Jasmijn E Klapwijk, Sam Riedijk, et al.
Pediatrics
|
June 24, 2026
Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older
Jacqueline Gerhart, Heidi Leister-Tebbe, Phylinda L S Chan, et al.
Page
of 7